BioLargo (BLGO) LD Micro Main Event XIX Investor Conference summary

Portfolio overview and innovation focus

• Four primary commercial assets target human health, sustainability, and environmental challenges, each positioned as best-in-class solutions.

• The company leverages partnerships and distribution to commercialize its technologies, focusing on filling market gaps.

• The portfolio includes energy storage, medical technology, environmental odor/VOC control, and engineering services.

• Each asset is at a different stage of market adoption, with some already generating significant revenue.

• The company emphasizes risk management and forward-looking execution.

Asset performance and valuation

• The energy storage business is considered the largest and most promising, with a scalable model based on selling battery factories rather than batteries.

• Clyra Medical, with $20 million invested and a recent $95 million valuation, is preparing for a major national launch and justifies the current market cap.

• PFAS treatment technology has a pipeline of over $200 million in contracts and is positioned as a cornerstone for environmental solutions.

• The ONM odor control asset generated $50 million in top-line revenue last year but is undergoing repositioning after a licensing dispute.

• Engineering services support innovation and have long-term contracts, including with the U.S. Air Force.

Technology and market differentiation

• The salinity battery technology offers 20-year durability, high energy density (552 Wh/kg), and safety advantages over lithium and sodium-sulfur batteries.

• The business model focuses on building and licensing battery factories globally, securing 19% carried interest and 6% royalty per factory.

• Four MOUs for 11 factories are in place, with a Series B valuation target of $400 million.

• The technology is positioned to address global supply chain risks and environmental concerns, appealing to sovereign wealth funds and local developers.

• Patent strategy includes refiling and reliance on trade secrets for manufacturing processes.